Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the benefits of testing the antibody levels of immunosuppressed or immunocompromised individuals given the spread of the Omicron variant of COVID-19.

There are currently no plans to implement targeted antibody testing for immunocompromised patients. However, clinicians in the National Health Service can arrange antibody testing based on their assessment of clinical need. Those with a cancer diagnosis may also be able to access free antibody tests through the National Cancer COVID Survey, which aims to assess levels of protection conferred by antibodies following vaccination/infection in cancer patients.  The Joint Committee on Vaccination and Immunisation will continue to review emerging scientific evidence on the use of vaccines in those who are immunocompromised and will update its advice as necessary.